Another study showed that the ERS effector PERK is upregulated in drug‐resistant cells of CRC and leads to tumor cell invasion and chemoresistance via the PERK/Nrf2/MRP1 axis.13 The gene discussed is EIF2AK3; the disease is colorectal carcinoma.